Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1231929-97-7

Post Buying Request

1231929-97-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • N-[5-[(4-Ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-2-pyrimidinamine

    Cas No: 1231929-97-7

  • USD $ 3.0-3.0 / Kilogram

  • 1 Kilogram

  • 1-100 Metric Ton/Month

  • Dayang Chem (Hangzhou) Co.,Ltd.
  • Contact Supplier

1231929-97-7 Usage

Biological Activity

ly2835219 is an orally available cyclin-dependent kinase (cdk) inhibitor that targets the cdk4 (cyclin d1) and cdk6 (cyclin d3) cell cycle pathway, with potential antineoplastic activity. cdk4/6 dual inhibitor ly2835219 specifically inhibits cdk4 and 6, thereby inhibiting retinoblastoma (rb) protein phosphorylation in early g1. inhibition of rb phosphorylation prevents cdk-mediated g1-s phase transition, thereby arresting the cell cycle in the g1 phase, suppressing dna synthesis and inhibiting cancer cell growth. overexpression of the serine/threonine kinases cdk4/6, as seen in certain types of cancer, causes cell cycle deregulation.

Enzyme inhibitor

This oral cell cycle inhibitor (FWfree-base = 506.61 g/mol; FWmesylate-salt = 602.70 g/mol; CAS 1231930-82-7 (mesylate salt) ), also known as LY2835219 and N-[5-[ (4-ethyl-1-piperazinyl) methyl]-2-pyridinyl]-5- fluoro-4-[4-fluoro-2-methyl-1- (1-methylethyl) -1H-benzimidazol-6-yl]-2- pyrimidinamine, targets the cyclin-dependent kinase CDK4, or cyclin D1 (IC50 = 2 nM) and CDK6, or cyclin D3 (IC50 = 6 nM), inhibiting retinoblastoma (Rb) protein phosphorylation in early G1, thereby arresting the cell cycle in the G1, suppressing DNA synthesis, and inhibiting cancer cell growth. LY2835219 inhibits activation of AKT and ERK, but not mTOR.

Check Digit Verification of cas no

The CAS Registry Mumber 1231929-97-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,1,9,2 and 9 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1231929-97:
(9*1)+(8*2)+(7*3)+(6*1)+(5*9)+(4*2)+(3*9)+(2*9)+(1*7)=157
157 % 10 = 7
So 1231929-97-7 is a valid CAS Registry Number.

1231929-97-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name N-[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine

1.2 Other means of identification

Product number -
Other names [5-(4-ethyl-piperazin-1-ylmethyl)-pyridin-2-yl]-[5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzoimidazol-5-yl)-pyrimidin-2-yl]-amine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1231929-97-7 SDS

1231929-97-7Synthetic route

6-(3-N,N-dimethylamino-2-fluoro-2-acrylketone-1-yl)-4-fluoro-1-isopropyl-2-methyl-1H-benzimidazole

6-(3-N,N-dimethylamino-2-fluoro-2-acrylketone-1-yl)-4-fluoro-1-isopropyl-2-methyl-1H-benzimidazole

N-[5-(4-ethylpiperazine-1-yl-methyl)pyridine-2-yl]guanidine nitrate

N-[5-(4-ethylpiperazine-1-yl-methyl)pyridine-2-yl]guanidine nitrate

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Stage #1: N-[5-(4-ethylpiperazine-1-yl-methyl)pyridine-2-yl]guanidine nitrate With sulfuric acid; sodium methylate In methanol; N,N-dimethyl-formamide at 30 - 35℃; for 2h;
Stage #2: 6-(3-N,N-dimethylamino-2-fluoro-2-acrylketone-1-yl)-4-fluoro-1-isopropyl-2-methyl-1H-benzimidazole at 80 - 85℃; for 7h;
90.8%
With sodium hydroxide In butan-1-ol at 90 - 100℃; Inert atmosphere;73.1%
5-((4-ethylpiperazin-1-yl)methyl)-6-methylpyridin-2-amine
1180132-17-5

5-((4-ethylpiperazin-1-yl)methyl)-6-methylpyridin-2-amine

6-bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole
1231930-33-8

6-bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
With palladium diacetate; potassium carbonate; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene at 98 - 100℃; Inert atmosphere;82.85%
4-ethylpiperazine
5308-25-8

4-ethylpiperazine

6-((5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)amino)nicotinaldehyde

6-((5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)amino)nicotinaldehyde

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
With formic acid; trimethyl orthoformate In acetonitrile at 80℃; for 16h; Reagent/catalyst; Leukardt-Wallach Amination; Sealed tube;74%
5-((4-ethylpiperazin-1-yl)methyl)-6-methylpyridin-2-amine
1180132-17-5

5-((4-ethylpiperazin-1-yl)methyl)-6-methylpyridin-2-amine

6-(2-chloro-5-fluoropyrimidin-4-yl)-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole
1231930-42-9

6-(2-chloro-5-fluoropyrimidin-4-yl)-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
With potassium carbonate; 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene; bis(dibenzylideneacetone)-palladium(0) In tert-Amyl alcohol at 100℃; for 19h;57.3%
With caesium carbonate; tris-(dibenzylideneacetone)dipalladium(0); 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene In 1,4-dioxane at 110℃; for 2h; Product distribution / selectivity; Inert atmosphere;
With tris-(dibenzylideneacetone)dipalladium(0); caesium carbonate; 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene In 1,4-dioxane at 110℃; for 2h; Reagent/catalyst; Solvent; Temperature; Inert atmosphere;22.11 g
4-fluoro-1-isopropyl-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolane-2-yl)-1H-benzo[d]imidazole
1231930-37-2

4-fluoro-1-isopropyl-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolane-2-yl)-1H-benzo[d]imidazole

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: sodium carbonate; bis-triphenylphosphine-palladium(II) chloride / water; 1,2-dimethoxyethane / 80 °C / Inert atmosphere
1.2: 5.5 h / 80 °C / Inert atmosphere
2.1: palladium dichloride; potassium carbonate / tert-Amyl alcohol / 18 h / 100 °C / Inert atmosphere
3.1: trimethyl orthoformate; formic acid / acetonitrile / 16 h / 80 °C / Sealed tube
View Scheme
Multi-step reaction with 2 steps
1: bis-triphenylphosphine-palladium(II) chloride; sodium carbonate / water; 1,2-dimethoxyethane / 1 h / 80 - 84 °C / Inert atmosphere
2: caesium carbonate; tris-(dibenzylideneacetone)dipalladium(0); 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene / 1,4-dioxane / 2 h / 110 °C / Inert atmosphere
View Scheme
N-isopropylacetamide
1118-69-0

N-isopropylacetamide

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: triethylamine; trichlorophosphate / toluene / 3 h / Reflux
2: potassium tert-butylate; N-Methylformamide / 70 - 75 °C / Large scale
3: tricyclohexylphosphine; potassium acetate; palladium diacetate / dimethyl sulfoxide / 1 h / 90 °C / Inert atmosphere
4: bis-triphenylphosphine-palladium(II) chloride; sodium carbonate / water; 1,2-dimethoxyethane / 1 h / 80 - 84 °C / Inert atmosphere
5: caesium carbonate; tris-(dibenzylideneacetone)dipalladium(0); 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene / 1,4-dioxane / 2 h / 110 °C / Inert atmosphere
View Scheme
Multi-step reaction with 3 steps
1: trichlorophosphate; triethylamine / toluene / 10 °C / Reflux
2: potassium hydroxide / toluene; dimethyl sulfoxide / 30 °C / Reflux
3: potassium carbonate; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene; palladium diacetate / 98 - 100 °C / Inert atmosphere
View Scheme
N-(4-bromo-2,6-difluorophenyl)-N'-isopropylacetamidine
1231930-29-2

N-(4-bromo-2,6-difluorophenyl)-N'-isopropylacetamidine

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: potassium tert-butylate; N-Methylformamide / 70 - 75 °C / Large scale
2: tricyclohexylphosphine; potassium acetate; palladium diacetate / dimethyl sulfoxide / 1 h / 90 °C / Inert atmosphere
3: bis-triphenylphosphine-palladium(II) chloride; sodium carbonate / water; 1,2-dimethoxyethane / 1 h / 80 - 84 °C / Inert atmosphere
4: caesium carbonate; tris-(dibenzylideneacetone)dipalladium(0); 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene / 1,4-dioxane / 2 h / 110 °C / Inert atmosphere
View Scheme
6-bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole
1231930-33-8

6-bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: tricyclohexylphosphine; potassium acetate; palladium diacetate / dimethyl sulfoxide / 1 h / 90 °C / Inert atmosphere
2: bis-triphenylphosphine-palladium(II) chloride; sodium carbonate / water; 1,2-dimethoxyethane / 1 h / 80 - 84 °C / Inert atmosphere
3: caesium carbonate; tris-(dibenzylideneacetone)dipalladium(0); 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene / 1,4-dioxane / 2 h / 110 °C / Inert atmosphere
View Scheme
4-ethylpiperazine
5308-25-8

4-ethylpiperazine

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sodium tris(acetoxy)borohydride / dichloromethane / 12 h / 20 - 30 °C / Large scale
2: ammonia / methanol / 40 - 75 °C
3: caesium carbonate; tris-(dibenzylideneacetone)dipalladium(0); 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene / 1,4-dioxane / 2 h / 110 °C / Inert atmosphere
View Scheme
6-bromonicotinaldehyde
149806-06-4

6-bromonicotinaldehyde

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sodium tris(acetoxy)borohydride / dichloromethane / 12 h / 20 - 30 °C / Large scale
2: ammonia / methanol / 40 - 75 °C
3: caesium carbonate; tris-(dibenzylideneacetone)dipalladium(0); 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene / 1,4-dioxane / 2 h / 110 °C / Inert atmosphere
View Scheme
1-((6-bromopyridin-3-yl)methyl)-4-ethylpiperazine
1231930-25-8

1-((6-bromopyridin-3-yl)methyl)-4-ethylpiperazine

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: ammonia / methanol / 40 - 75 °C
2: caesium carbonate; tris-(dibenzylideneacetone)dipalladium(0); 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene / 1,4-dioxane / 2 h / 110 °C / Inert atmosphere
View Scheme
4-bromo-2,6-difluoroaniline
67567-26-4

4-bromo-2,6-difluoroaniline

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: triethylamine; trichlorophosphate / toluene / 3 h / Reflux
2: potassium tert-butylate; N-Methylformamide / 70 - 75 °C / Large scale
3: tricyclohexylphosphine; potassium acetate; palladium diacetate / dimethyl sulfoxide / 1 h / 90 °C / Inert atmosphere
4: bis-triphenylphosphine-palladium(II) chloride; sodium carbonate / water; 1,2-dimethoxyethane / 1 h / 80 - 84 °C / Inert atmosphere
5: caesium carbonate; tris-(dibenzylideneacetone)dipalladium(0); 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene / 1,4-dioxane / 2 h / 110 °C / Inert atmosphere
View Scheme
Multi-step reaction with 3 steps
1: trichlorophosphate; triethylamine / toluene / 10 °C / Reflux
2: potassium hydroxide / toluene; dimethyl sulfoxide / 30 °C / Reflux
3: potassium carbonate; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene; palladium diacetate / 98 - 100 °C / Inert atmosphere
View Scheme
1-(4-amino-3,5-difluorophenyl)-2-fluoroethanone

1-(4-amino-3,5-difluorophenyl)-2-fluoroethanone

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: phosphorus trichloride; N-ethyl-N,N-diisopropylamine / 1,4-dioxane / 0 - 105 °C / Inert atmosphere
2: sodium hydride / toluene; mineral oil / 5 - 115 °C / Inert atmosphere
3: 5,5-dimethyl-1,3-cyclohexadiene / 120 - 130 °C / Inert atmosphere
4: sodium hydroxide / butan-1-ol / 90 - 100 °C / Inert atmosphere
View Scheme
Multi-step reaction with 4 steps
1: N,N-dimethyl-formamide / 140 - 150 °C / Inert atmosphere
2: phosphorus trichloride; triethylamine / toluene / 0 - 115 °C / Inert atmosphere
3: potassium tert-butylate / N,N-dimethyl-formamide / 5 - 150 °C
4: sodium hydroxide / butan-1-ol / 90 - 100 °C / Inert atmosphere
View Scheme
2,6-difluoroaniline
5509-65-9

2,6-difluoroaniline

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: trifluorormethanesulfonic acid / dichloromethane / 50 °C
2: phosphorus trichloride; N-ethyl-N,N-diisopropylamine / 1,4-dioxane / 0 - 105 °C / Inert atmosphere
3: sodium hydride / toluene; mineral oil / 5 - 115 °C / Inert atmosphere
4: 5,5-dimethyl-1,3-cyclohexadiene / 120 - 130 °C / Inert atmosphere
5: sodium hydroxide / butan-1-ol / 90 - 100 °C / Inert atmosphere
View Scheme
Multi-step reaction with 5 steps
1: trifluorormethanesulfonic acid / dichloromethane / 50 °C
2: N,N-dimethyl-formamide / 140 - 150 °C / Inert atmosphere
3: phosphorus trichloride; triethylamine / toluene / 0 - 115 °C / Inert atmosphere
4: potassium tert-butylate / N,N-dimethyl-formamide / 5 - 150 °C
5: sodium hydroxide / butan-1-ol / 90 - 100 °C / Inert atmosphere
View Scheme
1-(4-amino-2,6-difluorophenyl)-3-N,N-dimethylammonium-2-fluoro-2-acrylketone

1-(4-amino-2,6-difluorophenyl)-3-N,N-dimethylammonium-2-fluoro-2-acrylketone

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: phosphorus trichloride; triethylamine / toluene / 0 - 115 °C / Inert atmosphere
2: potassium tert-butylate / N,N-dimethyl-formamide / 5 - 150 °C
3: sodium hydroxide / butan-1-ol / 90 - 100 °C / Inert atmosphere
View Scheme
N-[2,6-difluoro-4-(3-N,N-dimethylamino-2-fluoro-2-acrylketone-1-yl)phenyl]-N’-isopropylethanamidine

N-[2,6-difluoro-4-(3-N,N-dimethylamino-2-fluoro-2-acrylketone-1-yl)phenyl]-N’-isopropylethanamidine

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium tert-butylate / N,N-dimethyl-formamide / 5 - 150 °C
2: sodium hydroxide / butan-1-ol / 90 - 100 °C / Inert atmosphere
View Scheme
N'-[2,6-difluoro-4-(2-fluoroethanone-1-yl)phenyl]-N-isopropylethanamidine

N'-[2,6-difluoro-4-(2-fluoroethanone-1-yl)phenyl]-N-isopropylethanamidine

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sodium hydride / toluene; mineral oil / 5 - 115 °C / Inert atmosphere
2: 5,5-dimethyl-1,3-cyclohexadiene / 120 - 130 °C / Inert atmosphere
3: sodium hydroxide / butan-1-ol / 90 - 100 °C / Inert atmosphere
View Scheme
6-(2-fluoroethanone-1-yl)-4-fluoro-1-isopropyl-2-methyl-1H-benzimidazole

6-(2-fluoroethanone-1-yl)-4-fluoro-1-isopropyl-2-methyl-1H-benzimidazole

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 5,5-dimethyl-1,3-cyclohexadiene / 120 - 130 °C / Inert atmosphere
2: sodium hydroxide / butan-1-ol / 90 - 100 °C / Inert atmosphere
View Scheme
5-((4-ethylpiperazin-1-yl)methyl)-6-methylpyridin-2-amine
1180132-17-5

5-((4-ethylpiperazin-1-yl)methyl)-6-methylpyridin-2-amine

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: nitric acid / ethanol; water / 0 - 80 °C / Inert atmosphere
2: sodium hydroxide / butan-1-ol / 90 - 100 °C / Inert atmosphere
View Scheme
1-(4-amino-3,5-difluorophenyl)ethan-1-one
811799-69-6

1-(4-amino-3,5-difluorophenyl)ethan-1-one

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: Selectfluor / methanol / 48 h
2: phosphorus trichloride; N-ethyl-N,N-diisopropylamine / 1,4-dioxane / 0 - 105 °C / Inert atmosphere
3: sodium hydride / toluene; mineral oil / 5 - 115 °C / Inert atmosphere
4: 5,5-dimethyl-1,3-cyclohexadiene / 120 - 130 °C / Inert atmosphere
5: sodium hydroxide / butan-1-ol / 90 - 100 °C / Inert atmosphere
View Scheme
Multi-step reaction with 5 steps
1: Selectfluor / methanol / 48 h
2: N,N-dimethyl-formamide / 140 - 150 °C / Inert atmosphere
3: phosphorus trichloride; triethylamine / toluene / 0 - 115 °C / Inert atmosphere
4: potassium tert-butylate / N,N-dimethyl-formamide / 5 - 150 °C
5: sodium hydroxide / butan-1-ol / 90 - 100 °C / Inert atmosphere
View Scheme
N-(4-bromo-2,6-difluorophenyl)-N'-isopropylethanimidamide

N-(4-bromo-2,6-difluorophenyl)-N'-isopropylethanimidamide

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium hydroxide / toluene; dimethyl sulfoxide / 30 °C / Reflux
2: potassium carbonate; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene; palladium diacetate / 98 - 100 °C / Inert atmosphere
View Scheme
3,5-difluoro-4-nitro-benzonitrile
1123172-88-2

3,5-difluoro-4-nitro-benzonitrile

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: potassium carbonate / N,N-dimethyl-formamide / 5 h / 60 - 65 °C / Autoclave
2.1: hydrogen / N,N-dimethyl-formamide / 9 h / 50 - 95 °C / 2250.23 - 3000.3 Torr / Autoclave; Inert atmosphere
3.1: tetrahydrofuran / 5 h / 30 - 35 °C
4.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / N,N-dimethyl-formamide / 6 h / 95 - 100 °C
5.1: sulfuric acid; sodium methylate / N,N-dimethyl-formamide; methanol / 2 h / 30 - 35 °C
5.2: 7 h / 80 - 85 °C
View Scheme
3-fluoro-4-nitro-5-isopropylaminobenzonitrile

3-fluoro-4-nitro-5-isopropylaminobenzonitrile

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: hydrogen / N,N-dimethyl-formamide / 9 h / 50 - 95 °C / 2250.23 - 3000.3 Torr / Autoclave; Inert atmosphere
2.1: tetrahydrofuran / 5 h / 30 - 35 °C
3.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / N,N-dimethyl-formamide / 6 h / 95 - 100 °C
4.1: sulfuric acid; sodium methylate / N,N-dimethyl-formamide; methanol / 2 h / 30 - 35 °C
4.2: 7 h / 80 - 85 °C
View Scheme
1-isopropyl-2-methyl-4-fluoro-6-cyano-1H-benzimidazole

1-isopropyl-2-methyl-4-fluoro-6-cyano-1H-benzimidazole

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: tetrahydrofuran / 5 h / 30 - 35 °C
2.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / N,N-dimethyl-formamide / 6 h / 95 - 100 °C
3.1: sulfuric acid; sodium methylate / N,N-dimethyl-formamide; methanol / 2 h / 30 - 35 °C
3.2: 7 h / 80 - 85 °C
View Scheme
methanesulfonic acid
75-75-2

methanesulfonic acid

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine
1231929-97-7

N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)-2-pyrimidinamine

[5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl]-[5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzoimidazol-5-yl)pyrimidin-2-yl]amine methanesulfonate

[5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl]-[5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzoimidazol-5-yl)pyrimidin-2-yl]amine methanesulfonate

Conditions
ConditionsYield
In methanol; dichloromethane for 1h;
In methanol; dichloromethane for 1h;20.4 g

1231929-97-7Relevant articles and documents

A synthesis of abemaciclib utilizing a Leuckart-Wallach reaction

Frederick, Michael O.,Kjell, Douglas P.

, p. 949 - 951 (2015)

A concise total synthesis of CDK 4/6 inhibitor abemaciclib is described. The synthesis uses a Suzuki coupling, followed by a Hartwig-Buchwald amination to join three of the four subunits. The final step is a reductive amination utilizing Leuckart-Wallach conditions. Key to the Leuckart-Wallach reaction was the addition of trimethyl orthoformate to remove water formed during the reaction, allowing the reaction to go to completion.

CRYSTALLINE POLYMORPHS OF ABEMACICLIB

-

, (2019/06/11)

The present disclosure provides novel polymorphs of abemaciclib, solid dispersions of abemaciclib with pharmaceutical excipients, and processes for the preparation thereof. The disclosure further provides methods for preparing crystalline abemaciclib form I, amorphous abemaciclib, and methods for synthesizing abemaciclib.

PREPARATION METHOD FOR BEMACICLB

-

, (2017/11/11)

Disclosed are an intermediate of bemaciclib or abemaciclib and a preparation method therefor. The preparation method comprises condensation, amidine reaction, cyclization and other unit reactions. Serving the intermediate of bemaciclib as a raw material, bemaciclib is obtained through the guanidination reaction and the cyclization reaction. According to the preparation method, the raw material is easily available, the procedure is simple, and the preparation method is economical, environmentally friendly and suitable for industrial production.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1231929-97-7